Indeed, a higher TNFRSF14 expression was significantly associated with a shorter survival for glioma patients and Cox regression models revealed that TNFRSF14 expression was an independent variable for predicting survival [43]. This evidence concerns the gene TNFRSF14 and central nervous system cancer.